Dr Ana-Mishel (AM) Spiroski and Ziad Mallat
Dec 18, 2025, 23:22
Dr Ana-Mishel (AM) Spiroski Shares Ziad Mallat’s Article: Translating Nobel Prize-Winning Treg Cell Science Into Cardiovascular Therapy
Dr Ana-Mishel (AM) Spiroski, Cardiovascular TA Lead, Age-Related Diseases TA Lead, Group Leader, In Vivo Pharmacology at Evotec, quoted Ziad Mallat’s post on LinkedIn:
“This is one of the most exciting areas in cardiovascular drug development. A fantastic comment by Professor Zallat Cambridge Cardiovascular on the potential of immune tolerance in cardiovascular therapeutics.”
Quoting Ziad Mallat’s post:
“Here’s the full PDF of the comment published in Nature Cardiovascular Reserach. Translating Nobel Prize-winning Treg cell science into cardiovascular therapy.”
Read full article here.
Follow the latest in Hemostasis Today.
-
Sep 15, 2026, 11:17Adam Urato: How SSRIs May Affect Maternal and Fetal Serotonin
-
Sep 15, 2026, 11:05Sudhir Kumar: Maternal Anemia May Shape a Child’s Brain Development
-
Sep 15, 2026, 10:48Ashok Singhal: A Life-Changing Transplant Brings New Hope for Beta Thalassemia
-
Sep 15, 2026, 10:33Vera Ghali: Mitapivat Opens a New Chapter in Thalassemia Treatment
-
Sep 15, 2026, 10:13Behnood Bikdeli: Exploring the Role of Antiphospholipid Antibodies in Ischemic Stroke
-
Sep 15, 2026, 09:55Mark Mamlouk: When Postpartum Headache Signals More Than a CSF Leak
-
Sep 15, 2026, 09:46Nicholas Raccagni: Heparin for VTE Prevention After Traumatic Brain Injury
-
Sep 15, 2026, 09:34Mario D. Caldararo: Are Lines of Zahn Pathognomonic for Antemortem Thrombosis?
-
Sep 15, 2026, 09:24Vishakha K. Kumar: ISTH Is Hiring – Exhibition and Sponsorship Operations Manager